TY - JOUR
T1 - Erratum
T2 - Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis (Journal of Hepatology (2019) 70(5) (930–940), (S0168827819300297), (10.1016/j.jhep.2018.12.038))
AU - Gwag, Taesik
AU - Meng, Zhaojie
AU - Sui, Yipeng
AU - Helsley, Robert N.
AU - Park, Se Hyung
AU - Wang, Shuxia
AU - Greenberg, Richard N.
AU - Zhou, Changcheng
N1 - Publisher Copyright:
© 2019 European Association for the Study of the Liver
PY - 2021/4
Y1 - 2021/4
N2 - It has come to our attention that there was a mistake in Fig. 6 in the published version of our manuscript. The mistake occurred during the publication process and has resulted in the labelling being inverted for the treatments with emtricitabine and efavirenz in the graph in Fig. 6A. Please see the corrected figure above. We apologize for any inconvenience caused.
AB - It has come to our attention that there was a mistake in Fig. 6 in the published version of our manuscript. The mistake occurred during the publication process and has resulted in the labelling being inverted for the treatments with emtricitabine and efavirenz in the graph in Fig. 6A. Please see the corrected figure above. We apologize for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85100320763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100320763&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2021.01.003
DO - 10.1016/j.jhep.2021.01.003
M3 - Comment/debate
C2 - 33526292
AN - SCOPUS:85100320763
SN - 0168-8278
VL - 74
SP - 1003
EP - 1004
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 4
ER -